3 Comments

Thank you for the following links:

1. The FDA Didn’t Inspect Neuralink Before Granting Human Trial Approval

2. Total Surveillance Society

Re: Neuralink — FDA seems to be ‘out of their league’ when it comes to staying on top of neuroscientific innovation. It’s sort of like the MDMA approval process which requires an understanding of psychedelics. It’s hard for FDA to regulate areas where they lack an expertise. And giving Neurolink a ‘go ahead’ shows how ineffectual our government agency has become as a safety oversight organization.

Expand full comment

There is a LOT of interesting stuff in here!

Expand full comment

Thanks Gareth, yes we think so too!

Expand full comment